Dear Women’s Imaging Insider,
In the age of personalized care, breast radiologists and clinicians alike are continuing to pinpoint specific factors impacting people’s risk of developing breast cancer.
One team out of the Mayo Clinic in Jacksonville, FL recently explored how benign breast disease detected on percutaneous biopsy is tied to women’s breast cancer risk. It found that the risk is similar to benign breast disease found via surgical biopsy. Read what else the team found in this edition’s featured article.
Also, the AuntMinnie.com team was recently in Chicago for the 2023 RSNA annual meeting, where many studies in breast cancer detection and risk assessment were presented.
One study presented by Robert Smith, PhD, of the American Cancer Society's Center for Cancer Screening found that mammography should still be the gold standard for preventing advanced, life-threatening breast cancers.
Another study showed that contrast-enhanced mammography (CEM) confirms the effectiveness of ultrasound-guided cryoablation and could serve as a reliable annual follow-up exam.
Also from RSNA, a study demonstrated how an AI algorithm correctly flagged minimal signs on digital mammography and digital breast tomosynthesis, as well as reading error misses.
Plus, the San Antonio Breast Cancer Symposium recently took place, presenting even more breast imaging-related research. Check out the following stories from the symposium:
- An Australian study found that CEM has utility as a surveillance tool for women with a personal history of breast cancer.
- Dynamic contrast-enhanced MRI (DCE-MRI) performs well in predicting early response to immunochemotherapy in women with triple-negative breast cancer, reported a team from the University of Texas MD Anderson Cancer Center in Houston.
- Researchers from the University of California, San Diego highlighted that restriction spectrum imaging (RSI) is a suitable method for evaluating neoadjuvant therapy response early for breast cancer.
- A Swedish study found that a mammography-based AI model showed good and generalizable performance across European screening populations.
Find more articles like these by visiting the Women’s Imaging content section!
